According to an article from Dental Office Magazine, Biolux Research, Vancouver, British Columbia, has received a nonrepayable financial contribution from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to help accelerate the development and commercialization of a new light treatment device for orthodontics.
The new product will be designed to accelerate tooth movement during orthodontic treatment, thus reducing treatment times and improving the patient’s experience.
NRC-IRAP will contribute approximately CAD $205,000 during the next 18 months to support the research and prototyping of the device; to clinically test and validate the effectiveness of the technology; and to develop a high-quality, manufacturable product.
"This financial support from the Government of Canada through NRC-IRAP is very positive for Biolux, and enables us to pursue our research and development of our new orthodontics product in a timely manner, and ultimately accelerates the commercialization of the product into the market," said Kevin Strange, president and CEO of Biolux.
